Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...
In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics. Before the COVID-19 pandemic, the pregnancy test was the ...
Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results